Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 527K
2: EX-10.16 Material Contract HTML 114K
3: EX-10.23 Material Contract HTML 140K
4: EX-10.25 Material Contract HTML 1.17M
5: EX-12 Statement re: Computation of Ratios HTML 32K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
16: R1 Document and Entity Information HTML 43K
17: R2 Consolidated Income Statements HTML 91K
18: R3 Consolidated Statements of Comprehensive Income HTML 52K
19: R4 Condensed Consolidated Balance Sheets HTML 121K
20: R5 Condensed Consolidated Balance Sheets HTML 36K
(Parenthetical)
21: R6 Condensed Consolidated Statements of Cash Flows HTML 103K
22: R7 Summary of Significant Accounting Policies HTML 47K
23: R8 Planned Merger with Dow Chemical Planned Merger HTML 38K
with Dow Chemical
24: R9 Divestitures and Other Transactions HTML 38K
25: R10 Employee Separation / Asset Related Charges, Net HTML 65K
26: R11 Other Income, Net HTML 62K
27: R12 Provision for Income Taxes HTML 30K
28: R13 Earnings Per Share of Common Stock HTML 51K
29: R14 Inventories HTML 35K
30: R15 Other Intangible Assets HTML 79K
31: R16 Short-Term and Long-Term Borrowings HTML 31K
32: R17 Commitments and Contingent Liabilities HTML 83K
33: R18 Stockholders' Equity HTML 133K
34: R19 Financial Instruments HTML 142K
35: R20 Long-Term Employee Benefits HTML 58K
36: R21 Segment Information HTML 101K
37: R22 Summary of Significant Accounting Policies Summary HTML 47K
of Significant Accounting Policies (Policies)
38: R23 Employee Separation / Asset Related Charges, Net HTML 61K
(Tables)
39: R24 Other Income, Net (Tables) HTML 62K
40: R25 Earnings Per Share of Common Stock (Tables) HTML 52K
41: R26 Inventories (Tables) HTML 36K
42: R27 Other Intangible Assets (Tables) HTML 76K
43: R28 Commitments and Contingent Liabilities (Tables) HTML 52K
44: R29 Stockholders' Equity (Tables) HTML 130K
45: R30 Financial Instruments (Tables) HTML 129K
46: R31 Long-Term Employee Benefits (Tables) HTML 57K
47: R32 Segment Information (Tables) HTML 102K
48: R33 Summary of Significant Accounting Policies Summary HTML 33K
of Significant Accounting Policies (Narrative)
(Details)
49: R34 Planned Merger with Dow Chemical Planned Merger HTML 36K
with Dow Chemical (Narrative) (Details)
50: R35 Divestitures and Other Transactions (Narrative) HTML 56K
(Details)
51: R36 Employee Separation / Asset Related Charges, Net HTML 61K
Employee Separation / Asset Related Charges, Net
(2017 Restructuring Program schedule) (Details)
52: R37 Employee Separation / Asset Related Charges, Net HTML 36K
Employee Separation / Asset Related Charges, Net
(La Porte) (Narrative) (Details)
53: R38 Employee Separation / Asset Related Charges, Net HTML 66K
Employee Separation / Asset Related Charges, Net
(2016 Restructuring Program schedule )(Details)
54: R39 Other Income, Net (Schedule of Other Income) HTML 66K
(Details)
55: R40 Other Income, Net (Schedule of Foreign Exchange HTML 36K
Gain (Loss)) (Details)
56: R41 Provision for Income Taxes (Details) HTML 32K
57: R42 Earnings Per Share of Common Stock (Earnings Per HTML 48K
Share of Common Stock Reconciliation) (Details)
58: R43 Earnings Per Share of Common Stock (Schedule of HTML 29K
Average Number of Antidilutive Stock Options)
(Details)
59: R44 Inventories (Details) HTML 37K
60: R45 Other Intangible Assets (Schedule of Other HTML 66K
Intangible Assets) (Details)
61: R46 Other Intangible Assets (Narrative) (Details) HTML 44K
62: R47 Short-Term and Long-Term Borrowings (Details) HTML 57K
63: R48 Commitments and Contingent Liabilities HTML 55K
(Guarantees) (Details)
64: R49 Commitments and Contingent Liabilities HTML 122K
(Litigation) (Narrative) (Details)
65: R50 Commitments and Contingent Liabilities Commitments HTML 38K
and Contingent Liabilities (Environmental)
(Narrative) (Details)
66: R51 Stockholders' Equity Stockholder's Equity HTML 59K
(Details)
67: R52 Stockholders' Equity Stockholder's Equity HTML 30K
(Schedule of tax benefit (Expense) on Net
Activity) (Details) (Details)
68: R53 Stockholders' Equity Stockholders' Equity HTML 68K
(Reclassifications out of accumulated other
Comprehensive Income / (Loss)) (Details) (Details)
69: R54 Financial Instruments Financial Insttruments HTML 51K
(Schedule of Cash, Cash Equivalents and Marketable
Securities) (Details)
70: R55 Financial Instruments (Debt) (Narrative) (Details) HTML 26K
71: R56 Financial Instruments (Notional Amounts of HTML 32K
Derivatives) (Details)
72: R57 Financial Instruments (Effect of Cash Flows Hedges HTML 38K
on Accumulated Other Comprehensive Income (Loss))
(Details)
73: R58 Financial Instruments (Schedule of the Fair Value HTML 52K
of Derivative Instruments) (Details)
74: R59 Financial Instruments (Effect of Derivative HTML 52K
Instruments) (Details)
75: R60 Long-Term Employee Benefits (Schedules of Net HTML 59K
Periodic Benefit Cost) (Details)
76: R61 Segment Information (Schedule of Segment HTML 48K
Information) (Details)
77: R62 Segment Information (Reconciliation to HTML 68K
Consolidated Income Statements) (Details)
78: R63 Segment Information (Significant Pre-tax (charges) HTML 86K
benefits not included in Segment Operating
Earnings) (Details)
80: XML IDEA XML File -- Filing Summary XML 143K
79: EXCEL IDEA Workbook of Financial Reports XLSX 89K
10: EX-101.INS XBRL Instance -- dd-20170331 XML 2.43M
12: EX-101.CAL XBRL Calculations -- dd-20170331_cal XML 198K
13: EX-101.DEF XBRL Definitions -- dd-20170331_def XML 940K
14: EX-101.LAB XBRL Labels -- dd-20170331_lab XML 1.57M
15: EX-101.PRE XBRL Presentations -- dd-20170331_pre XML 1.03M
11: EX-101.SCH XBRL Schema -- dd-20170331 XSD 201K
81: ZIP XBRL Zipped Folder -- 0000030554-17-000016-xbrl Zip 251K
‘EXCEL’ — IDEA Workbook of Financial Reports
This is an IDEA Workbook.
1 Subsequent Filing that References this Filing
↑Top
Filing Submission 0000030554-17-000016 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Wed., May 1, 12:55:15.1am ET 
